We are live on ! Find out more
ARIA

Ariad Pharmaceuticals Inc
ARIA

Delisted

ARIA was delisted on the 15th of February, 2017.

Back to rankings

182 hedge funds and large institutions have $1.04B invested in Ariad Pharmaceuticals Inc in 2016 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 65 increasing their positions, 45 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more funds holding in top 10

Funds holding in top 10: 2 → 7 (+5)

105% more first-time investments, than exits

New positions opened: 41 | Existing positions closed: 20

44% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 45

20% more capital invested

Capital invested by funds: $867M → $1.04B (+$169M)

13% more call options, than puts

Call options by funds: $13.8M | Put options by funds: $12.2M

12% more funds holding

Funds holding: 162 → 182 (+20)

Holders
182
Holders Change
+20
Holders Change %
+12.35%
% of All Funds
4.86%
Holding in Top 10
7
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+250%
% of All Funds
0.19%
New
41
Increased
65
Reduced
45
Closed
20
Calls
$13.8M
Puts
$12.2M
Net Calls
+$1.64M
Net Calls Change
-$1.88M

Top Buyers

Rank Fund Capital Flow
1
CCM
Consonance Capital Management
New York
+$24.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
+$19.4M
3
Goldman Sachs
Goldman Sachs
New York
+$8.84M
4
CC
CQS Cayman
Cayman Islands
+$8.49M
5
Invesco
Invesco
Georgia
+$6.32M

Top Sellers

Rank Fund Capital Flow
1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$35.6M
2
PI
Putnam Investments
Massachusetts
-$23.9M
3
CCM
Camber Capital Management
Massachusetts
-$10.5M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
-$8.2M
5
PC
PointState Capital
New York
-$6.75M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of New York Mellon
26
Bank of New York Mellon
New York
$7.66M +$1.34M +178,750 +21%
Deutsche Bank
27
Deutsche Bank
Germany
$7.13M +$1.3M +173,118 +22%
HS
28
HighVista Strategies
Massachusetts
$6.42M +$465K +62,000 +8%
Invesco
29
Invesco
Georgia
$6.34M +$6.32M +842,317 +5,501%
Morgan Stanley
30
Morgan Stanley
New York
$6M +$4.1M +545,817 +205%
JCM
31
JS Capital Management
New York
$5.97M -$458K -61,000 -7%
OAM
32
Oxford Asset Management
United Kingdom
$5.61M -$1.7M -225,922 -23%
Charles Schwab
33
Charles Schwab
California
$4.98M +$869K +115,774 +21%
BIM
34
BlackRock Investment Management
Delaware
$4.91M +$574K +76,515 +13%
RPAM
35
Rhenman & Partners Asset Management
Sweden
$4.62M +$188K +25,000 +4%
PP
36
PDT Partners
New York
$4.57M – – –
TCIM
37
TIAA CREF Investment Management
New York
$4.26M +$124K +16,539 +3%
Adage Capital Partners
38
Adage Capital Partners
Massachusetts
$4.16M -$35.6M -4,750,000 -89%
JP Morgan Chase
39
JP Morgan Chase
New York
$4M +$1.74M +232,153 +75%
TCM
40
Tekla Capital Management
Massachusetts
$3.71M +$3.77M +502,000 New
CCM
41
Cadian Capital Management
New York
$3.69M +$3.75M +500,000 New
BG
42
Bellevue Group
Switzerland
$3.66M – – –
AllianceBernstein
43
AllianceBernstein
Tennessee
$3.52M +$1.01M +134,400 +39%
ARTA
44
A.R.T. Advisors
New York
$3.24M +$3.29M +438,817 New
GPCM
45
Granite Point Capital Management
Massachusetts
$3.18M +$3.23M +430,890 New
RA
46
Royce & Associates
New York
$2.77M – – –
California State Teachers Retirement System (CalSTRS)
47
California State Teachers Retirement System (CalSTRS)
California
$2.74M +$115K +15,319 +4%
California Public Employees Retirement System
48
California Public Employees Retirement System
California
$2.61M -$82.5K -11,000 -3%
GC
49
Guggenheim Capital
Illinois
$2.6M -$196K -26,101 -7%
TA
50
Teachers Advisors
New York
$2.5M +$247K +32,919 +11%
1
2
3 4 5

ARIA Hedge Fund Activity: Q2 2016 in Review

182 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Ariad Pharmaceuticals Inc (ARIA) for Q2 2016, worth a combined $1.04B — up 20% from $867M a quarter earlier.

Buyers outnumbered sellers: 41 funds opened new ARIA positions and 20 closed out — a net gain of 21 holders — while 65 added to existing stakes and 45 trimmed.

The largest buyer was Consonance Capital Management, adding an estimated $24.5M. The largest seller was Adage Capital Partners, cutting an estimated $35.6M.

  • 182 institutional investors held Ariad Pharmaceuticals Inc (ARIA) as of Q2 2016, up from 162 in Q1 2016.
  • Funds reported $1.04B of Ariad Pharmaceuticals Inc stock for Q2 2016, up 20% quarter-over-quarter.
  • 41 funds opened new Ariad Pharmaceuticals Inc positions in Q2 2016 and 20 closed out, a net change of +21 holders.
  • The largest Ariad Pharmaceuticals Inc buyer in Q2 2016 was Consonance Capital Management, an estimated $24.5M added.
  • The largest Ariad Pharmaceuticals Inc seller in Q2 2016 was Adage Capital Partners, an estimated $35.6M sold.

Based on aggregated 13F filings for Q2 2016.